Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001

L Paz-Ares, RC Doebele, AF Farago, SV Liu, SP Chawla, D Tosi, CM Blakely, JC Krauss, D Sigal, L Bazhenova, T John, B Besse, J Wolf, T Seto, E Chow-Maneval, C Ye, B Simmons, GD Demetri